Farms.com Home   News

Government of Canada supporting expanded market opportunities for the organic industry

Minister of Agriculture and Agri-Food Marie-Claude Bibeau was at Kwantlen Polytechnic University where she highlighted a recent funding announcement of $992,131 for the CanadaOrganic Trade Association.
 
The investment, made under the Canadian Agricultural Partnership's AgriMarketing Program, will support the industry in resolving market access issues, ensuring Canadian organic products remain competitive. The funding will also help create export and domestic opportunities to promote the "Canada Organic" brand.
 
The project includes activities such as attending trade shows, hosting incoming missions, participating at international trade advocacy meetings and creating a retailer training webinar series and manual.
 
The Government of Canada has also recently supported a review of organic standards and has provided program support to the Organic Federation of Canada to help maintain the sector's sustainability.
Source : Government Of Canada

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.